Modern Chinese Medicine Group Co., Ltd. has scheduled a Board meeting for Friday, 28 August 2026. Directors will review and approve the consolidated interim results for the six months ended 30 June 2026 and decide on a potential interim dividend declaration.
The announcement, dated 13 August 2026, lists the current Board composition as three executive directors—Sun Xinlei, Zhang Hongli and Jia Yanru—and three independent non-executive directors—Liu Ling, Leung Tsz Wing and Wong Chi Kin.
Any resolutions passed, including the interim results and dividend recommendation, will be released to the market following Board approval.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments